Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
Details for Australian Patent Application No. 2006304321 (hide)
International Classifications
Event Publications
8 May 2008 PCT application entered the National Phase
PCT publication WO2007/047512 Priority application(s): WO2007/047512
15 May 2008 Amendment Made
The nature of the amendment is: Amend the invention title to read Inhibition of PAX2 by DEFB1 induction as a therapy for cancer
17 July 2008 Amendment Made
The nature of the amendment is: Amend the invention title to read: Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
13 November 2008 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 21 Oct 2008
4 October 2012 Application Accepted
Published as AU-B-2006304321
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006304325-A vehicle data acquisition system and host controller
2006304318-Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser